We are live on ! Find out more
WRM

Weybosset Research & Management Portfolio holdings

AUM $347M
1-Year Est. Return 29.87%
This Fund
S&P 500
This Quarter Est. Return
+7.17%
1 Year Est. Return
+29.87%
3 Year Est. Return
+64.94%
5 Year Est. Return
10 Year Est. Return
AUM
$191M
AUM Growth
+$16.5M
Cap. Flow
+$4.63M
Cap. Flow %
2.42%
Top 10 Hldgs %
54.7%
Holding
58
New
15
Increased
14
Reduced
16
Closed

Top Buys

Rank Stock Value
1
ITW icon
Illinois Tool Works
ITW
+$436K
2
AMGN icon
Amgen
AMGN
+$413K
3
UPS icon
United Parcel Service
UPS
+$386K
4
MMM icon
3M
MMM
+$377K
5
ABBV icon
AbbVie
ABBV
+$369K

Top Sells

Rank Stock Value
1
CPRT icon
Copart
CPRT
+$311K
2
CL icon
Colgate-Palmolive
CL
+$134K
3
KEYS icon
Keysight
KEYS
+$116K
4
DE icon
Deere & Co
DE
+$33.6K
5
FMC icon
FMC
FMC
+$33.5K

Sector Composition

Rank Sector Weight
1 Industrials 36.08%
2 Financials 14.8%
3 Technology 12.27%
4 Consumer Discretionary 9.32%
5 Healthcare 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRT icon
1
Copart
CPRT
$25.9B
$20.1M 10.49%
882,848
-14,568
-2% -$311K
KEYS icon
2
Keysight
KEYS
$54.5B
$12.2M 6.37%
118,840
-1,135
-0.9% -$116K
DE icon
3
Deere & Co
DE
$170B
$10.3M 5.41%
59,712
-195
-0.3% -$33.6K
AGM icon
4
Federal Agricultural Mortgage
AGM
$2.27B
$9.92M 5.19%
118,843
+5
+0% +$416
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.07T
$9.62M 5.03%
42,492
-146
-0.3% -$31.7K
TJX icon
6
TJX Companies
TJX
$170B
$9.12M 4.77%
149,387
+121
+0.1% +$7.15K
FMC icon
7
FMC
FMC
$1.42B
$8.7M 4.54%
87,112
-360
-0.4% -$33.5K
JNJ icon
8
Johnson & Johnson
JNJ
$635B
$8.64M 4.52%
59,266
-84
-0.1% -$11.4K
EGOV
9
DELISTED
NIC Inc
EGOV
$8.18M 4.27%
366,040
-605
-0.2% -$13.2K
CNI icon
10
Canadian National Railway
CNI
$78.3B
$7.88M 4.12%
87,071
+317
+0.4% +$28.5K
APTV icon
11
Aptiv
APTV
$12B
$7.41M 3.87%
78,043
+515
+0.7% +$47.2K
CMI icon
12
Cummins
CMI
$91.7B
$7.36M 3.84%
41,111
+255
+0.6% +$44.9K
GD icon
13
General Dynamics
GD
$105B
$7.19M 3.76%
40,748
-22
-0.1% -$3.95K
INGR icon
14
Ingredion
INGR
$6.38B
$6.7M 3.5%
72,111
-275
-0.4% -$23.1K
NYT icon
15
New York Times
NYT
$11.6B
$6.65M 3.48%
206,820
+2,105
+1% +$65.4K
LH icon
16
Labcorp
LH
$24.3B
$6.64M 3.47%
45,693
-81
-0.2% -$11.7K
OZK icon
17
Bank OZK
OZK
$5.49B
$6.51M 3.4%
213,281
+5,180
+2% +$152K
HPQ icon
18
HP
HPQ
$23.5B
$5.61M 2.93%
273,164
+2,095
+0.8% +$39.7K
HXL icon
19
Hexcel
HXL
$8.32B
$4.78M 2.5%
65,210
+2,040
+3% +$157K
CL icon
20
Colgate-Palmolive
CL
$72.6B
$4.61M 2.41%
66,960
-1,969
-3% -$134K
TCP
21
DELISTED
TC Pipelines LP
TCP
$3.54M 1.85%
83,574
-226
-0.3% -$8.94K
JKHY icon
22
Jack Henry & Associates
JKHY
$10.7B
$2.76M 1.44%
18,929
-35
-0.2% -$5.11K
XOM icon
23
ExxonMobil
XOM
$651B
$1.48M 0.77%
21,153
-15
-0.1% -$1.04K
AAPL icon
24
Apple
AAPL
$4.89T
$1.07M 0.56%
14,616
LTHM
25
DELISTED
Livent Corporation
LTHM
$1.07M 0.56%
124,726
+8,418
+7% +$64.4K

Similar funds

Weybosset Research & Management's Q4 2019 Portfolio in Review

As of Q4 2019, Weybosset Research & Management held 58 positions worth $191M, up 9.5% from $175M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Weybosset Research & Management's Q4 2019 filing shows 15 new, 14 increased and 16 reduced positions. Its largest new stake was Illinois Tool Works: 2,575 shares worth $463K. The largest sale was Copart, an estimated $311K.

By sector, the portfolio is most concentrated in Industrials at 36% of assets, down from 37% a quarter earlier, followed by Financials and Technology.

  • Weybosset Research & Management's largest Q4 2019 buy was Illinois Tool Works: 2,575 shares worth $463K.
  • Weybosset Research & Management added most to Hexcel in Q4 2019, an estimated $157K increase.
  • Weybosset Research & Management's biggest Q4 2019 reduction was Copart, cutting an estimated $311K.
  • Weybosset Research & Management's ten largest holdings make up 55% of its $191M portfolio in Q4 2019.
  • Weybosset Research & Management opened 15 new positions and closed 0 in Q4 2019.
  • Weybosset Research & Management's portfolio value rose 9.5% quarter-over-quarter to $191M.

Based on Weybosset Research & Management's 13F filing for Q4 2019, filed 27 Jan 2020.